Brinton Pharmaceuticals has raised about $1.35 million (Rs 10 crore) in debt funding from Mumbai based non-banking financial company BlackSoil Capital, per an announcement.
The company will use the funds for its growth plans, the company said in a statement.
Pune-based Brinton Pharmaceuticals Ltd is engaged in the marketing and distribution of branded generic drugs and differentiated brands with a focus on niche therapeutic segments, including dermatology, gynecology, anti-diabetic therapy, cardiac therapy, among others.
The company also counts Beta TC Holdings Pte Ltd and India Alternatives Private Equity Fund among its list of backers.
INDIA DEAL MONITOR
Here are prominent venture capital transactions in India from September 16-20, 2020.
